Article Versions Notes

Cuttone A, Cannavò V, Abdullah RMS, Fugazzotto P, Arena G, Brancati S, Muscarà A, Morace C, Quartarone C, Ruggeri D, et al. Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings. Cells. 2025; 14(9):668. https://doi.org/10.3390/cells14090668

Cuttone, Alessandro, Vittorio Cannavò, Raouf Mastan Sheik Abdullah, Pierluigi Fugazzotto, Giada Arena, Simona Brancati, Andrea Muscarà, Carmela Morace, Cristina Quartarone, Domenica Ruggeri, and et al. 2025. "Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings" Cells 14, no. 9: 668. https://doi.org/10.3390/cells14090668

Cuttone, A., Cannavò, V., Abdullah, R. M. S., Fugazzotto, P., Arena, G., Brancati, S., Muscarà, A., Morace, C., Quartarone, C., Ruggeri, D., Squadrito, G., & Russo, G. T. (2025). Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings. Cells, 14(9), 668. https://doi.org/10.3390/cells14090668